04:39 PM EDT, 03/13/2024 (MT Newswires) -- MedMira Inc. ( MMIRF ) announced after trade Wednesday the receipt of a Canadian patent patent for its "new innovative and quantitative test system". This, it said in a statement, is in addition to the U.S. patent received in 2022.

The company said through this it will further diversify its patent portfolio and expand on its Rapid Vertical Flow Technology (RVF) based diagnostic tests. It added: "This is a step forward in empowering the company's strategic vision by offering a rapid multiplexed quantitative diagnostic system from screening to confirmation to monitoring disease progression. The synergies between both patented technologies allow MedMira ( MMIRF ) to continue its corporate aim to provide the market with a highly effective and affordable alternative to the current costly and time-consuming screening and monitoring systems."